Cumberland, RI, United States of America

William Martin

This inventor holds 28 USPTO granted patents and 16 published patent applications, plus 1 CIPO patent and 9 EPO patents, primarily in Immunotherapy Research. Top assignees: Epivax, Inc., Faac, Inc., The United States of America, as Represented by the Secretary, Department of Health and Human Services. Active years: 2011-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William Martin. Retrieved from https://idiyas.com/inventor/william-martin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 28 (Patent Applications = 16)

% Patents Active = 64.3

CIPO Patents = 1 (Patent Applications = 5)

EPO Patents = 9 (Patent Applications = 16)

Average Co-Inventor Count = 3.3

ph-index = 3

Forward Citations = 94(Granted Patents)

Location History:

Cumberland, RI (US) (2011 - 2021)
Cumerland, RI (US) (2021 - 2024)
Perrysburg, OH (US) (2021 - 2024)
Providence, RI (US) (2022 - 2024)

Company Filing History:

The United States of America, as Represented by the Secretary, Department of Health and Human Services

Food and Drug Administration

patent

6. 1 out of 8

Rhode Island Council on Postsecondary Education

patents

where one patent can have more than one assignee

Years Active: 2011-2025

Loading Chart...

Areas of Expertise:

Regulatory T Cell Epitopes

Driving Simulation

Pharmaceutical Compositions

De-Immunized Factor VIII

Pump Operation Panel

Hepatitis C Virus

Modified H7 Hemagglutinin

Influenza A

Scoring Systems

Epitopes Compositions

Simulators

28 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12347342 - Driving simulation scoring system (2025-07-01),

2. 12275956 - Regulatory T cell epitopes (2025-04-14),

3. 12264191 - De-immunized factor VIII molecule and pharmaceutical compositions comprising the same (2025-04-01),

4. 12230165 - Driving simulation scoring system (2025-02-18),

5. 12115403 - Pump operation panel simulator (2024-10-15),

6. 12016909 - Regulatory T cell epitopes, compositions and uses thereof (2024-06-25),

7. 11911414 - Regulatory T cell epitopes (2024-02-27),

8. 11857818 - Pump operation panel simulator (2024-01-02),

9. 11844826 - Regulatory T cell epitopes, compositions and uses thereof (2023-12-19),

10. 11583716 - Pump operation panel simulator (2023-02-21),

11. 11441122 - Regulatory T cell epitopes (2022-09-13),

12. 11244579 - Driving simulation scoring system (2022-02-08),

13. 11132916 - Driving simulation scoring system (2021-09-28),

14. 11045532 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),

15. 11045531 - Regulatory T cell epitopes, compositions and uses thereof (2021-06-29),

Title: Inventor William Martin: A Leader in Immunological Innovations

Introduction

William Martin, hailing from Cumberland, Rhode Island, is a notable inventor with a remarkable portfolio of 19 patents. His work primarily focuses on advancements in immunology, particularly concerning regulatory T cell epitopes, which play a crucial role in immune response regulation.

Latest Patents

William Martin's latest patents include innovative inventions related to T cell epitopes. One such patent discusses a composition of regulatory T cell epitopes that encompass a peptide or polypeptide chain, comprising at least a portion of an immunoglobulin's constant or variable region. The invention outlines various methods for utilizing these epitopes, highlighting their significance in therapeutic applications.

Another recent patent describes regulatory T cell epitopes that comprise a polypeptide constructed from specific sequences (SEQ ID NOS: 1-124) and their fragments or variants. This invention also explores avenues for producing these epitopes and their potential uses in research and clinical settings.

Career Highlights

In his professional journey, William Martin has collaborated with esteemed organizations like Epivax, Inc. and the Rhode Island Council on Postsecondary Education. His contributions at these institutions have been pivotal in advancing the field of immunology, particularly through the development of innovative therapeutic solutions.

Collaborations

Throughout his career, William has had the opportunity to work alongside distinguished professionals, including Anne Searls De Groot and Daniel S. Rivera. These collaborations have not only enriched his research but have also fostered an environment of innovation and discovery in the scientific community.

Conclusion

William Martin stands out as a significant figure in the realm of immunological inventions. With 19 patents to his name, his contributions have the potential to revolutionize therapeutic approaches and enhance our understanding of immune regulation. His work continues to inspire others in the field of biomedical research and innovation.

Profile summary based on public USPTO records.